Medicine Description cidophage-retard 850mg
Cidophage Retard is a medication that combines glibenclamide and metformin to manage blood glucose levels in individuals with type 2 diabetes mellitus. Glibenclamide, a sulfonylurea, stimulates the pancreas to release more insulin by binding to specific receptors on pancreatic beta cells. This action enhances insulin secretion in response to elevated glucose levels. Metformin, on the other hand, operates primarily by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues, particularly muscle and fat. Together, these two components work synergistically to lower blood sugar levels while minimizing the risk of hypoglycemia compared to insulin therapy alone.
Indications and Uses of Cidophage Retard
- Management of non-insulin-dependent type 2 diabetes mellitus in adults when lifestyle modifications are insufficient.
- Used as monotherapy or in combination with other oral hypoglycemic agents to achieve better glycemic control.
- May be prescribed alongside insulin therapy for enhanced blood glucose regulation.
Side Effects of Cidophage Retard
- Nausea
- Vomiting
- Diarrhea
- Abdominal discomfort
- Hypoglycemia
- Lactic acidosis (rare but serious)
- Skin reactions or allergic responses
Storage and Handling
Store Cidophage Retard at room temperature, away from excess heat and moisture. Keep it in its original packaging to protect from light. Ensure it is out of reach of children.
Patient Advice and Precautions
Patients should monitor blood glucose levels regularly to ensure effective management of diabetes. It is essential to maintain a balanced diet and adhere to prescribed exercise routines. Inform healthcare providers of any other medications being taken to avoid interactions. Regular check-ups are recommended to assess kidney function, as both components can affect renal health.